work-life balance
Scope
Date
~
-
[Interview] NongHyup Life eyes hedge fund, private equity secondary investments
NongHyup Life Insurance Co. Ltd., a unit of South Korea’s agricultural cooperative, will commit an additional 700 billion won ($620 mn) to overseas al...
Feb 27, 2017 (Gmt+09:00)
-
[Interview] Hanwha Life targets senior secured debt; sees $1 bn net growth in 2017 alternative asset
Hanwha Life Insurance Co. Ltd., which manages 100 trillion won ($87 billion) of assets, will chase senior secured debts of commercial buildings in dev...
Feb 14, 2017 (Gmt+09:00)
-
[Interview] Mirae Asset Life eyes US power plants, buildings to boost overseas investment
(This is the first in a series of interviews with CIOs of South Korea’s leading insurance companies in 2017.) Mirae Asset Life Insurance Co. Ltd., ...
Feb 10, 2017 (Gmt+09:00)
-
Hanwha Life, scientist fund to put $230 mn into UK gas business bid
South Korea’s Hanwha Life Insurance Co. Ltd. and a scientists’ savings fund will commit a total of 185 million pounds ($230 million) to a project fund...
Nov 29, 2016 (Gmt+09:00)
-
KIC, Teachers’ Pension to invest in US warehouse fund, first since joint work agreement
Korea Investment Corporation (KIC) and the Teachers’ Pension will invest in a U.S. warehouse portfolio fund for an undisclosed sum, in their first joi...
Nov 09, 2016 (Gmt+09:00)
-
Samsung Life
Samsung Life Insurance Co. has agreed to buy a 25% stake in Savills Investment Management (Savills IM), the investment arm of the UK-based real estate...
1 MINUTES AGO
-
Korea’s current account balance
.s-table-container { overflow: hidden; background: -webkit-linear-gradient(left, #f7ffe1, #f7ffe1); ...
1 MINUTES AGO
Latest News
- 1 Google to invest $100 mn in Gentle Monster in smart glasses push
- 2 Growth equity portfolio largely shielded from policy headwinds: Summit
- 3 Naver Financial seeks to acquire S. Korean real estate data platform Asil
- 4 KakaoBank shares surge on Thai virtual bank approval
- 5 Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma